Altimmune, Inc. (ALT)
3.62
-0.06
(-1.63%)
USD |
NASDAQ |
Dec 30, 12:52
Altimmune Total Liabilities (Quarterly): 32.85M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | 26.38M |
| Amgen, Inc. | 80.52B |
| Rhythm Pharmaceuticals, Inc. | 358.06M |
| Terns Pharmaceuticals, Inc. | 17.58M |
| X4 Pharmaceuticals, Inc. | 101.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 218.45M |
| Shareholders Equity (Quarterly) | 185.60M |
| Debt to Equity Ratio | 0.0857 |
| Current Ratio | 17.18 |
| Net Debt Paydown Yield | -0.78% |